Our mission is to abolish chronic lymphocytic leukemia (CLL) as a threat to the life and health of patients by accelerating CLL research.

CLL Global Research Foundation started as a mere idea from a couple of CLL patients. Six years later, CLL Global has funded $16.4 million to researchers all over the world who are making headway in the advancement of CLL research. Thanks to the generosity of our supporters, great strides have been made to eliminate CLL.

Together, we are solving the CLL research puzzle.

PRESIDENT'S CORNER
Dr. Michael Keating

Featured Article: Don’t Forget to Add Your Name to the Gift List

Welcome Message:
Welcome to the CLL Global Research Foundation web site. Our goal is to eliminate chronic lymphocytic leukemia (CLL) as a threat to life by funding outstanding research aimed at eradicating this disease. Read more.

Dr. Michael Keating, professor of medicine at MD Anderson Cancer Center, serves as president and CEO of the CLL Global Research Foundation. He is an internationally renowned CLL clinical scientist dedicated to patient care and to development of potentially curative CLL therapies.